A detailed history of Investment Partners, Ltd. transactions in Eli Lilly & CO stock. As of the latest transaction made, Investment Partners, Ltd. holds 6,520 shares of LLY stock, worth $5.01 Million. This represents 2.42% of its overall portfolio holdings.

Number of Shares
6,520
Previous 6,520 -0.0%
Holding current value
$5.01 Million
Previous $5.9 Million 2.15%
% of portfolio
2.42%
Previous 2.66%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$724.87 - $909.04 $22,470 - $28,180
-31 Reduced 0.47%
6,520 $5.9 Million
Q1 2024

Apr 15, 2024

BUY
$592.2 - $792.28 $1,184 - $1,584
2 Added 0.03%
6,551 $5.1 Million
Q4 2023

Feb 02, 2024

SELL
$525.19 - $619.13 $41,490 - $48,911
-79 Reduced 1.19%
6,549 $3.82 Million
Q3 2023

Oct 31, 2023

SELL
$434.7 - $599.3 $235,607 - $324,820
-542 Reduced 7.56%
6,628 $3.56 Million
Q2 2023

Aug 07, 2023

BUY
$350.74 - $468.98 $2,455 - $3,282
7 Added 0.1%
7,170 $3.36 Million
Q1 2023

May 08, 2023

BUY
$310.63 - $364.82 $2,795 - $3,283
9 Added 0.13%
7,163 $2.46 Million
Q4 2022

Jan 17, 2023

SELL
$321.55 - $374.67 $703,229 - $819,403
-2,187 Reduced 23.41%
7,154 $0
Q3 2022

Oct 21, 2022

BUY
$296.48 - $337.87 $799,013 - $910,559
2,695 Added 40.55%
9,341 $3.02 Million
Q2 2022

Aug 05, 2022

BUY
$278.73 - $327.27 $1,672 - $1,963
6 Added 0.09%
6,646 $2.16 Million
Q1 2022

Apr 22, 2022

SELL
$234.69 - $291.66 $41,540 - $51,623
-177 Reduced 2.6%
6,640 $1.9 Million
Q4 2021

Feb 04, 2022

BUY
$224.85 - $279.04 $226,199 - $280,714
1,006 Added 17.31%
6,817 $1.88 Million
Q3 2021

Oct 13, 2021

BUY
$221.6 - $272.71 $1,329 - $1,636
6 Added 0.1%
5,811 $1.34 Million
Q2 2021

Jul 15, 2021

BUY
$180.55 - $233.54 $1,083 - $1,401
6 Added 0.1%
5,805 $1.33 Million
Q1 2021

May 06, 2021

BUY
$164.32 - $212.72 $985 - $1,276
6 Added 0.1%
5,799 $1.08 Million
Q4 2020

Jan 19, 2021

SELL
$130.46 - $172.63 $21,786 - $28,829
-167 Reduced 2.8%
5,793 $978,000
Q3 2020

Nov 09, 2020

SELL
$146.22 - $169.13 $227,518 - $263,166
-1,556 Reduced 20.7%
5,960 $882,000
Q2 2020

Aug 06, 2020

SELL
$136.42 - $164.18 $12,414 - $14,940
-91 Reduced 1.2%
7,516 $1.23 Million
Q1 2020

Apr 29, 2020

BUY
$119.05 - $147.35 $171,193 - $211,889
1,438 Added 23.31%
7,607 $1.06 Million
Q4 2019

Jan 31, 2020

BUY
$106.92 - $132.43 $855 - $1,059
8 Added 0.13%
6,169 $811,000
Q3 2019

Oct 17, 2019

BUY
$106.79 - $116.16 $14,416 - $15,681
135 Added 2.24%
6,161 $689,000
Q2 2019

Jul 30, 2019

SELL
$110.79 - $129.32 $31,353 - $36,597
-283 Reduced 4.49%
6,026 $668,000
Q1 2019

May 03, 2019

BUY
$111.31 - $131.02 $779 - $917
7 Added 0.11%
6,309 $819,000
Q4 2018

Jan 15, 2019

BUY
$105.9 - $118.64 $635 - $711
6 Added 0.1%
6,302 $729,000
Q3 2018

Oct 29, 2018

BUY
$85.86 - $107.31 $540,574 - $675,623
6,296 New
6,296 $482,000
Q3 2018

Oct 25, 2018

SELL
$85.86 - $107.31 $539,973 - $674,872
-6,289 Closed
0 $0
Q2 2018

Jul 25, 2018

SELL
$75.7 - $86.88 $90,234 - $103,560
-1,192 Reduced 15.93%
6,289 $537,000
Q1 2018

May 03, 2018

BUY
$74.21 - $87.6 $1,781 - $2,102
24 Added 0.32%
7,481 $579,000
Q4 2017

Jan 31, 2018

SELL
$81.94 - $87.89 $5,489 - $5,888
-67 Reduced 0.89%
7,457 $630,000
Q3 2017

Oct 30, 2017

BUY
$77.07 - $85.54 $579,874 - $643,602
7,524
7,524 $644,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Investment Partners, Ltd. Portfolio

Follow Investment Partners, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Investment Partners, Ltd. with notifications on news.